In the specialized field of peptide chemistry, few building blocks have garnered as much interest as peptide Aib. K Aminoisobutyric acid (Aib), a non-proteinogenic α,α-disubstituted amino acid,has emerged as a powerful tool in peptide chemistryand drug design.Read more nown formally as 2-Ami Aminoisobutyric Acid (Aib), Unusual Amino noisobutyric acid, this non-proteinogenic amino acid—often identified by the CAS number 62-57-7—has become a cornerstone for researchers aiming to stabilize peptide secondary structures. My experience working with these compounds has highlighted why they are so vital for structural biology and experimental design.
Understanding the Aib Entity
2-Aminoisobutyric acid is a unique, quaternary amino acid. Unlike standard proteinogenic amino acids, it features a twofold substitution at the α-carbon. This specific structural configuration is what makes it a powerful helix inducer. When I incorporate Aib into a sequence, I am essent Aminoisobutyricacid (Aib) is an example of a simple quaternary amino acid, and it is a strong helix inducer that forms 3 10 -helices on oligomerization.Read more ially leveraging its ability to restrict the conformational space of the peptide backbone, effectively promoting the formation of 3₁₀-helices or β-turns.
For those conducting a review of Aminoisobutyric Acid (Aib), it is clear that its primary utility lies in its rigidity. Because Aib is a non-proteinogenic amino acid, it resists proteolytic degradation, making it a critical component when designing stable peptide analogs.
Technical Applications and Synthesis
In my lab, we frequently utilize automated solid-phase peptide synthesis to concatenate these residues. The use of building blocks like Fmoc-Ile-Aib-OH has simplified the process of creating complex, Aib-rich architectures.
The integration of Aib-containing peptide analogs has opened doors to exploring structure-activity relationships that were previously difficult to stabilize. Furthermore, incorporation of Aib is a feasible strategy to create peptide helical mimics with enhanced receptor binding. Whether working with Aib/Ala-containing peptides or investigating the structural characteristics of α-helical peptide molecules containing Aib residues, the precision afforded by this amino acid is unmatched.
Structural Influence and Research Focus
The field of peptides is vast, but Aib remains a focal point due to its presence in peptaibols—a class of fungal antibiotics. Indeed, it is an amino acid that significantly influences the secondary structure of peptaibols, contributing to their characteristic helical geometry.
Beyond natural products, Aib is extensively used to optimize peptide therapeutics. By replacing sensitive amino acid cleavage sites with Aib, researchers can create scaffolds that are far more robust than their natural counterparts. My own observations confirm that Aib-containing peptide analogs can even be engineered for specifi 2-Aminoisobutyric Acid (CAS 62-57-7) c cellular uptake, demonstrating the versatility of this molecule.
Why Aib Matters
* Non-Proteinogenic Nature: Being a non-standard amino acid, it provides resistance to enzymatic breakdown.
* Helix Induction: Its unique geometry is the gold standard for stabilizing 3₁₀-helices.
* Synthetic Versatility: Aib is an amino acid used in solution-phase peptide synthesis and is highly compatible with modern solid-phase techniques.
* Tool for Discovery: Aib has emerged as a powerful tool in peptide chemist Z-Aib-OH [15030-72-5] ry, helping us study everything from Amyloid beta peptide (Aβ42) aggregation to the creation of novel metal-peptide frameworks.
From a research 2-Aminoisobutyric acid also known as α-aminobutyric acid,is an amino acid used in solution-phase peptide synthesis. It is a desirable building block for Read more standpoint, the precision of AIB—often referred to by its single-letter code or as 2-Aminoisobutyric acid—allows for the creation of highly ordered, predictable molecular architectures. As we continue to push the boundaries of synthetic biology, the role of Aminoisobutyric acid will undoubtedly remain central to the development of sta Aib-containing peptide analogs: cellular uptake and ble, functional, and well-defined Aib peptides.
Whether you are exploring the nuances of α-Aminoisobutyric acid (Aib)-containing peptide analogs or simply refining your synthesis protocols, the evidence clearly points to Aib as an indispensable asset in the chemist's toolkit.